Therapeutic application of multipotent stem cells

Journal of Cellular Physiology

Volumn 233, Issue 4, 2018, Pages 2815-2823

  Mirzaei, Hamed ^a   Sahebkar, Amirhossein ^a   Sichani, Laleh Shiri ^b   Moridikia, Abdullah ^c   Nazari, Sara ^d   Nahand, Javid Sadri ^e   Salehi, Hossein ^f   Stenvang, Jan ^g   Masoudifar, Aria ^h   Mirzaei, Hamid R ⁱ   Jaafari, Mahmoud R ^j  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHREKORD UNIVERSITY   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

^h ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

ⁱ TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^j MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

more..

Author keywords

Differentiation; Multipotent stem cells; Therapy

Indexed keywords

ANTIAPOPTOTIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CANCER THERAPY; CELL DIFFERENTIATION; CELL ISOLATION; DISEASES; HUMAN; MULTIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL SELF-RENEWAL; STEM CELL TRANSPLANTATION; THERAPY EFFECT; ANIMAL; CELL SEPARATION; CLINICAL TRIAL (TOPIC); CYTOLOGY; NEOPLASM; TRANSPLANTATION;

ANIMALS; CELL SEPARATION; CLINICAL TRIALS AS TOPIC; HUMANS; MULTIPOTENT STEM CELLS; NEOPLASMS; STEM CELL TRANSPLANTATION;

EID: 85021227833     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25990     Document Type: Review

References (98)

1. Aggarwal, S., & Pittenger, M. F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105(4), 1815–1822.
2. Alison, M. R., Poulsom, R., Forbes, S., & Wright, N. A. (2002). An introduction to stem cells. The Journal of Pathology, 197(4), 419–423.
3. Assinck, P., Duncan, G. J., Hilton, B. J., Plemel, J. R., & Tetzlaff, W. (2017). Cell transplantation therapy for spinal cord injury. Nature Neuroscience, 20(5), 637–647.
4. Behr, L., Hekmati, M., Fromont, G., Borenstein, N., Noel, L. H., Lelievre-Pegorier, M., & Laborde, K. (2007). Intra renal arterial injection of autologous mesenchymal stem cells in an ovine model in the postischemic kidney. Nephron Physiology, 107(3), 65–76.
5. Blanpain, C., & Fuchs, E. (2014). Plasticity of epithelial stem cells in tissue regeneration. Science, 344(6189), 1242281.
6. Bongso, A., & Fong, C.-Y. (2009). Human embryonic stem cells: Their nature, properties, and uses. Trends in Stem Cell Biology and Technology (pp. 1–17). Switzerland: Humana Press Springer. https://doi.org/10.1007/978-1-60327-905-5_1
7. Boonbaichaiyapruck, S., Pienvichit, P., Limpijarnkij, T., Rerkpattanapipat, P., Pongpatananurak, A., Saelee, R., …Hongeng, S. (2010). Transcoronary infusion of bone marrow derived multipotent stem cells to preserve left ventricular geometry and function after myocardial infarction. Clinical Cardiology, 33(7), 20545.
8. Breitbach, M., Bostani, T., Roell, W., Xia, Y., Dewald, O., Nygren, J. M., … Hescheler, J. (2007). Potential risks of bone marrow cell transplantation into infarcted hearts. Blood, 110(4), 1362–1369.
9. Caplan, A. I., & Bruder, S. P. (2001). Mesenchymal stem cells: Building blocks for molecular medicine in the 21st century. Trends in Molecular Medicine, 7(6), 259–264.
10. Chamberlain, G., Fox, J., Ashton, B., & Middleton, J. (2007). Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells, 25(11), 2739–2749.
11. Chen, Q., Cheng, P., Song, N., Yin, T., He, H., Yang, L., … Wei, Y. (2012). Antitumor activity of placenta-derived mesenchymal stem cells producing pigment epithelium-derived factor in a mouse melanoma model. Oncology Letters, 4(3), 413–418.
12. Chepeleva, E. V., Pavlova, S. V., Malakhova, A. A., Milevskaya, E. A., Rusakova, Y. L., Podkhvatilina, N. A., …Zakiyan, S. M. (2015). Therapy of chronic cardiosclerosis in WAG rats using cultures of cardiovascular cells enriched with cardiac stem cell. Bulletin of Experimental Biology and Medicine, 160(1), 165–173.
13. Choi, S. A., Lee, J. Y., Wang, K.-C., Phi, J. H., Song, S. H., Song, J., & Kim, S.-K. (2012a). Human adipose tissue-derived mesenchymal stem cells: Characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas. European Journal of Cancer, 48(1), 129–137.
14. Clevers, H. (2015). What is an adult stem cell? Science, 350(6266), 1319–1320.
15. Dai, R., Wang, Z., Samanipour, R., Koo, K.-i, & Kim, K. (2016) Adipose-derived stem cells for tissue engineering and regenerative medicine applications. Stem Cells International, 2016, 6737345.
16. Doorn, J., van de Peppel, J., van Leeuwen, J. P., Groen, N., van Blitterswijk, C. A., & de Boer, J. (2011). Pro-osteogenic trophic effects by PKA activation in human mesenchymal stromal cells. Biomaterials, 32(26), 6089–6098.
17. Duan, X., Guan, H., Cao, Y., & Kleinerman, E. S. (2009). Murine bone marrow-derived mesenchymal stem cells as vehicles for interleukin-12 gene delivery into Ewing sarcoma tumors. Cancer, 115(1), 13–22.
18. El-Ansary, M., Abdel-Aziz, I., Mogawer, S., Abdel-Hamid, S., Hammam, O., Teaema, S., & Wahdan, M. (2012). Phase II trial: Undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Reviews, 8(3), 972–981.
19. Fathullahzadeh, S., Mirzaei, H., Honardoost, M. A., Sahebkar, A., & Salehi, M. (2016). Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia. Cancer Gene Therapy, 23(10), 327–332.
20. Fu, W. L., Zhou, C. Y., & Yu, J. K. (2014). A new source of mesenchymal stem cells for articular cartilage repair: MSCs derived from mobilized peripheral blood share similar biological characteristics in vitro and chondrogenesis in vivo as MSCs from bone marrow in a rabbit model. American Journal of Sports Medicine, 42(3), 592–601.
21. Gao, P., Ding, Q., Wu, Z., Jiang, H., & Fang, Z. (2010). Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma. Cancer Letters, 290(2), 157–166.
22. Gargett, C. E. (2007). Review article: Stem cells in human reproduction. Reproductive Sciences, 14(5), 405–424.
23. Gnecchi, M., He, H., Noiseux, N., Liang, O. D., Zhang, L., Morello, F., … Ingwall, J. S. (2006). Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. The FASEB Journal, 20(6), 661–669.
24. Gronthos, S., Franklin, D. M., Leddy, H. A., Robey, P. G., Storms, R. W., & Gimble, J. M. (2001). Surface protein characterization of human adipose tissue-derived stromal cells. Journal of Cellular Physiology, 189(1), 54–63.
25. Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N., Strumpf, R. K., Schulman, S. P., … Sherman, W. (2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Journal of the American College of Cardiology, 54(24), 2277–2286.
26. Haynesworth, S. E., Baber, M. A., & Caplan, A. I. (1996). Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1α. Journal of Cellular Physiology, 166(3), 585–592.
27. Herberts, C. A., Kwa, M. S., & Hermsen, H. P. (2011). Risk factors in the development of stem cell therapy. Journal of Translational Medicine, 9(1), 29.
28. Hoseini, Z., Sepahvand, F., Rashidi, B., Sahebkar, A., Masoudifar, A., & Mirzaei, H. (2017). NLRP3 inflammasome: Its regulation and involvement in atherosclerosis. Journal of Cellular Physiology, 27(10), 25930.
29. Hu, M., Yang, J. L., Teng, H., Jia, Y. Q., Wang, R., Zhang, X. W., …Wei, Y. Q. (2008). Anti-angiogenesis therapy based on the bone marrow-derived stromal cells genetically engineered to express sFlt-1 in mouse tumor model. BMC Cancer, 8, 306.
30. Ittrich, H., Lange, C., Togel, F., Zander, A. R., Dahnke, H., Westenfelder, C., …Nolte-Ernsting, C. (2007). In vivo magnetic resonance imaging of iron oxide-labeled, arterially-injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury: Detection and monitoring at 3T. Journal of Magnetic Resonance Imaging, 25(6), 1179–1191.
31. Iwasa, T., Baba, S., Doi, H., Kaichi, S., Yokoo, N., Mima, T.,… Heike, T. (2010). Neonatal mouse testis-derived multipotent germline stem cells improve the cardiac function of acute ischemic heart mouse model. Biochemical and Biophysical Research Communications, 400(1), 27–33.
32. Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., … Blackstad, M. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 418(6893), 41–49.
33. Kanehira, M., Xin, H., Hoshino, K., Maemondo, M., Mizuguchi, H., Hayakawa, T., …Saijo, Y. (2007). Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells. Cancer Gene Therapy, 14(11), 894–903.
34. Karussis, D., Karageorgiou, C., Vaknin-Dembinsky, A., Gowda-Kurkalli, B., Gomori, J. M., Kassis, I., …Slavin, S. (2010). Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Archives of Neurology, 67(10), 1187–1194.
35. Keshavarzi, M., Darijani, M., Momeni, F., Moradi, P., Ebrahimnejad, H., Masoudifar, A., & Mirzaei, H. (2017). Molecular Imaging and oral cancer diagnosis and therapy. Journal of Cellular Biochemistry, 8(10), 26042.
36. Keshavarzi, M., Rezaie, M. J., Sorayayi, S., Mohammadi, M., Ghaderi, A., Rostamzadeh, A., … Mirzaei, H. (2017). MicroRNAs-based imaging techniques in cancer diagnosis and therapy. Journal of Cellular Biochemistry, 29(10), 26012.
37. Kim, J., Shapiro, L., & Flynn, A. (2015). The clinical application of mesenchymal stem cells and cardiac stem cells as a therapy for cardiovascular disease. Pharmacology Therapy, 151, 8–15.
38. Kim, S. W., Han, H., Chae, G. T., Lee, S. H., Bo, S., Yoon, J. H., …Kang, K. S. (2006). Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger’s disease and ischemic limb disease animal model. Stem Cells, 24(6), 1620–1626.
39. Kuo, T. K., Hung, S. P., Chuang, C. H., Chen, C. T., Shih, Y. R. V., Fang, S. C. Y., … Lee, O. K. (2008). Stem cell therapy for liver disease: Parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology, 134(7), 2111–2121.
40. Lan, Y. W., Choo, K. B., Chen, C. M., Hung, T. H., Chen, Y. B., Hsieh, C. H., … Chong, K. Y. (2015). Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis. Stem Cell Research Therapy, 6(97), 015–0081.
41. Lee, N., Thorne, T., Losordo, D. W., & Yoon, Y. S. (2005). Repair of ischemic heart disease with novel bone marrow-derived multipotent stem cells. Cell Cycle, 4(7), 861–864.
42. Lee, R. H., Seo, M. J., Reger, R. L., Spees, J. L., Pulin, A. A., Olson, S. D., & Prockop, D. J. (2006). Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proceedings of the National Academy of Sciences of the United States of America, 103(46), 17438–17443.
43. Li, H., Stoicov, C., Rogers, A. B., & Houghton, J. (2006). Stem cells and cancer: Evidence for bone marrow stem cells in epithelial cancers. World Journal of Gastroenterology, 12(3):363–371.
44. Li, L., Guan, Y., Liu, H., Hao, N., Liu, T., Meng, X., …Tang, F. (2011). Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. ACS Nano, 5(9), 7462–7470.
45. Li, X., Lu, Y., Huang, W., Xu, H., Chen, X., Geng, Q., … Jiang, X. (2006). In vitro effect of adenovirus-mediated human Gamma Interferon gene transfer into human mesenchymal stem cells for chronic myelogenous leukemia. Hematological Oncology, 24(3), 151–158.
46. Liao, S.-Y., & Tse, H.-F. (2013). Multipotent (adult) and pluripotent stem cells for heart regeneration: What are the pros and cons? Stem Cell Research & Therapy, 4(6), 151.
47. Liu, Y. H., Peng, K. Y., Chiu, Y. W., Ho, Y. L., Wang, Y. H., Shun, C. T., …Yen, M. L. (2015). Human placenta-derived multipotent cells (hPDMCs) modulate cardiac injury: From bench to small and large animal myocardial ischemia studies. Cell Transplantation, 24(12), 2463–2478.
48. Loebinger, M. R., Eddaoudi, A., Davies, D., & Janes, S. M. (2009). Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Research, 69(10), 4134–4142.
49. Mathieu, J., & Ruohola-Baker, H. (2013). Regulation of stem cell populations by microRNAs. Advances in Experimental Medicine and Biology, 786, 329–351.
50. Mirzaei, H., Fathullahzadeh, S., Khanmohammadi, R., Darijani, M., Momeni, F., Masoudifar, A., …Mirzaei, H. R. (2017). State of the art in MicroRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia. Journal of Cellular Physiology, 13(10), 25799.
51. Mirzaei, H., Khataminfar, S., Mohammadparast, S., Sales, S. S., Maftouh, M., Mohammadi, M., …Avan, A. (2016). Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in gastric cancer: Current status and future perspectives. Current Medicinal Chemistry, 23(36), 4135–4150.
52. Mirzaei, H., Naseri, G., Rezaee, R., Mohammadi, M., Banikazemi, Z., Mirzaei, H. R., …Sahebkar, A. (2016). Curcumin: A new candidate for melanoma therapy? International Journal of Cancer, 139(8), 1683–1695.
53. Mirzaei, H., Sahebkar, A., Avan, A., Jaafari, M. R., Salehi, R., Salehi, H., … Mirzaei, H. R. (2016). Application of mesenchymal stem cells in melanoma: A potential therapeutic strategy for delivery of targeted agents. Current Medicinal Chemistry, 23(5), 455–463.
54. Mirzaei, H., Sahebkar, A., Jaafari, M. R., Goodarzi, M., & Mirzaei, H. R. (2016). Diagnostic and therapeutic potential of exosomes in cancer: The beginning of a new tale? Journal of Cellular Physiology, 14(10), 25739.
55. Mirzaei, H., Yazdi, F., Salehi, R., & Mirzaei, H. R. SiRNA and epigenetic aberrations in ovarian cancer. Journal of Cancer Research and Therapeutics, 12(2), 498.
56. Mohammadi, M., Goodarzi, M., Jaafari, M. R., Mirzaei, H. R., & Mirzaei, H. (2016). Circulating microRNA: A new candidate for diagnostic biomarker in neuroblastoma. Cancer Gene Therapy, 23(11), 371–372.
57. Mohammadi, M., Jaafari, M., Mirzaei, H., & Mirzaei, H. (2016). Mesenchymal stem cell: A new horizon in cancer gene therapy. Cancer Gene Therapy, 23(9), 285–286.
58. Moridikia, A., Mirzaei, H., Sahebkar, A., & Salimian, J. (2017). MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer. Journal of Cellular Physiology, 16(10), 25801.
59. Morigi, M., Introna, M., Imberti, B., Corna, D., Abbate, M., Rota, C., … Remuzzi, G. (2008). Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells, 26(8), 2075–2082.
60. Murphy, M. B., Moncivais, K., & Caplan, A. I. (2013). Mesenchymal stem cells: Environmentally responsive therapeutics for regenerative medicine. Experimental & Molecular Medicine, 45(11), e54.
61. Nadig, R. R. (2009). Stem cell therapy-Hype or hope? A review. Journal of Conservative Dentistry, 12(4), 131.
62. Nakamura, K., Ito, Y., Kawano, Y., Kurozumi, K., Kobune, M., Tsuda, H., … Hamada, H. (2004). Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Therapy, 11(14), 1155–1164.
63. Nussbaum, J., Minami, E., Laflamme, M. A., Virag, J. A., Ware, C. B., Masino, A., … Murry, C. E. (2007). Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. The FASEB Journal, 21(7), 1345–1357.
64. Ong, S. G., & Wu, J. C. (2015). Exosomes as potential alternatives to stem cell therapy in mediating cardiac regeneration. Circulation Research, 117(1), 7–9. https://doi.org/10.1161/CIRCRESAHA.115.306593
65. Peng, L., Xie, D. Y., Lin, B. L., Liu, J., Zhu, H. P., Xie, C., …Gao, Z. L. (2011). Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes. Hepatology, 54(3), 820–828.
66. Penney, K. L. (2017). Molecular and genetic epidemiology of cancer. Pathology and epidemiology of cancer (pp. 83–89). Switzerland: Springer International Publishing. https://doi.org/10.1007/978-3-319-35153-7_7
67. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., …Marshak, D. R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284(5411), 143–147.
68. Rashidi, B., Hoseini, Z., Sahebkar, A., & Mirzaei, H. (2016). Anti-atherosclerotic effects of vitamins d and e in suppression of atherogenesis. Journal of Cellular Physiology, 14(10), 25738.
69. Rashidi, B., Malekzadeh, M., Goodarzi, M., Masoudifar, A., & Mirzaei, H. (2017). Green tea and its anti-angiogenesis effects. Biomedicine and Pharmacotherapy, 89, 949–956.
70. Ren, C., Kumar, S., Chanda, D., Kallman, L., Chen, J., Mountz, J. D., & Ponnazhagan, S. (2008). Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model. Gene Therapy, 15(21), 1446–1453.
71. Saadatpour, L., Fadaee, E., Fadaei, S., Nassiri Mansour, R., Mohammadi, M., Mousavi, S. M., … Mirzaei, H. (2016). Glioblastoma: Exosome and microRNA as novel diagnosis biomarkers. Cancer Gene Therapy, 23(12), 415–418.
72. Saadatpour, Z., Bjorklund, G., Chirumbolo, S., Alimohammadi, M., Ehsani, H., Ebrahiminejad, H., … Sahebkar, A. (2016). Molecular imaging and cancer gene therapy. Cancer Gene Therapy. https://doi.org/10.1038/cgt.2016.62. [Epub ahead of print].
73. Saadatpour, Z., Rezaei, A., Ebrahimnejad, H., Baghaei, B., Bjorklund, G., Chartrand, M., … Mirzaei, H. (2016c). Imaging techniques: New avenues in cancer gene and cell therapy. Cancer Gene Therapy, 24(1):1–5.
74. Salarinia, R., Sahebkar, A., Peyvandi, M., Mirzaei, H. R., Jaafari, M. R., Riahi, M. M., … Mirzaei, H. (2016). Epi-drugs and epi-miRs: Moving beyond current cancer therapies. Current Cancer Drug Targets, 16(9), 773–788.
75. Schäffler, A., & Büchler, C. (2007). Concise review: Adipose tissue-derived stromal cells—basic and clinical implications for novel cell-based therapies. Stem Cells, 25(4), 818–827.
76. Segers, V. F., & Lee, R. T. (2008). Stem-cell therapy for cardiac disease. Nature, 451(7181), 937–942.
77. Shah, K., Tung, C.-H., Breakefield, X. O., & Weissleder, R. (2005). In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis. Molecular Therapy, 11(6), 926–931.
78. Shi, M., Zhang, Z., Xu, R., Lin, H., Fu, J., Zou, Z., …Wang, F. S. (2012). Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Translational Medicine, 1(10), 725–731.
79. Smith, A. (2005). The battlefield of pluripotency. Cell, 123(5), 757–760.
80. Sobhani, A., Khanlarkhani, N., Baazm, M., Mohammadzadeh, F., Najafi, A., Mehdinejadiani, S., & Aval, F. S. (2017). Multipotent stem cell and current application. Acta Medica Iranica, 55(1), 6–23.
81. Stoff-Khalili, M. A., Rivera, A. A., Mathis, J. M., Banerjee, N. S., Moon, A. S., Hess, A., …Chow, L. T. (2007). Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Research and Treatment, 105(2), 157–167.
82. Stuckey, D. W., Hingtgen, S. D., Karakas, N., Rich, B. E., & Shah, K. (2014). Engineering toxin-resistant therapeutic stem cells to treat brain tumors. Stem Cells, 33(2):589–600.
83. Studeny, M., Marini, F. C., Champlin, R. E., Zompetta, C., Fidler, I. J., & Andreeff, M. (2002). Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Research, 62(13), 3603–3608.
84. Telukuntla, K. S., Suncion, V. Y., Schulman, I. H., & Hare, J. M. (2013). The advancing field of cell-based therapy: Insights and lessons from clinical trials. Journal of American Heart Association, 2(5), 000338.
85. Trounson, A., & McDonald, C. (2015). Stem cell therapies in clinical trials: Progress and challenges. Cell Stem Cell, 17(1), 11–22.
86. Trounson, A., Thakar, R. G., Lomax, G., & Gibbons, D. (2011). Clinical trials for stem cell therapies. BMC Medicine, 9(1), 52.
87. Tsao,C.R.,Liao,M.F.,Wang,M.H.,Cheng,C.M.,&Chen,C.H. (2014). Mesenchymal stem cell derived exosomes: A new hope for the treatment of cardiovascular disease? Acta Cardiol Sin, 30(5), 395–400.
88. Tuan, R. S. (2006). Stemming cartilage degeneration: Adult mesenchymal stem cells as a cell source for articular cartilage tissue engineering. Arthritis & Rheumatism, 54(10), 3075–3078.
89. Tyagi, A. C., Sen, U., & Mishra, P. K. (2011). Synergy of microRNA and stem cell: A novel therapeutic approach for diabetes mellitus and cardiovascular diseases. Current Diabetes Reviews, 7(6), 367–376.
90. Uchibori, R., Okada, T., Ito, T., Urabe, M., Mizukami, H., Kume, A., & Ozawa, K. (2009). Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy. The Journal of Gene Medicine, 11(5), 373–381.
91. Werbowetski-Ogilvie, T. E., Bossé, M., Stewart, M., Schnerch, A., Ramos-Mejia, V., Rouleau, A., …Carter, T. (2009). Characterization of human embryonic stem cells with features of neoplastic progression. Nature Biotechnology, 27(1), 91–97.
92. Wu, K. J., Yu, S. J., Chiang, C. W., Cho, K. H., Lee, Y. W., Yen, B. L., …Wang, Y. (2015). Transplantation of human placenta-derived multipotent stem cells reduces ischemic brain injury in adult rats. Cell Transplantation, 24(3), 459–470.
93. Wuidart, A., Ousset, M., Rulands, S., Simons, B. D., Van Keymeulen, A., & Blanpain, C. (2016). Quantitative lineage tracing strategies to resolve multipotency in tissue-specific stem cells. Genes & Development, 30(11), 1261–1277.
94. Xiang, J., Tang, J., Song, C., Yang, Z., Hirst, D. G., Zheng, Q. J., & Li, G. (2009). Mesenchymal stem cells as a gene therapy carrier for treatment of fibrosarcoma. Cytotherapy, 11(5), 516–526.
95. Xin, H., Kanehira, M., Mizuguchi, H., Hayakawa, T., Kikuchi, T., Nukiwa, T., & Saijo, Y. (2007). Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells. Stem Cells, 25(7), 1618–1626.
96. Xu, G., Jiang, X.-D., Xu, Y., Zhang, J., Huang, F.-H., Chen, Z.-Z., …Cai, Y.-Q. (2009). Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats. Cell Biology International, 33(4), 466–474.
97. Zhang, W., Qin, C., & Zhou, Z. M. (2007). Mesenchymal stem cells modulate immune responses combined with cyclosporine in a rat renal transplantation model. Transplantation Proceedings, 39(10), 3404–3408.
98. Zhang, W. G., He, L., Shi, X. M., Wu, S. S., Zhang, B., Mei, L., …Zhang, H. L. (2014). Regulation of transplanted mesenchymal stem cells by the lung progenitor niche in rats with chronic obstructive pulmonary disease. Respiratory Research, 15(33), 1465–9921.